Free Trial

ESGEN Acquisition (ESACW) 10K Form and Latest SEC Filings 2026

$0.05 0.00 (-8.55%)
As of 05/1/2026

Latest ESGEN Acquisition SEC Filings & Recent Activity

ESGEN Acquisition (NASDAQ:ESACW) has submitted 157+ documents to the U.S. Securities and Exchange Commission (SEC) since 2022. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 8-K submitted on April 24, 2026.

8-K
ESGEN Acquisition Files Current Report on Apr. 24, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
ESGEN Acquisition Files Quarterly Report on Nov. 14, 2025

The 10-Q contains ESGEN Acquisition's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

ESGEN Acquisition SEC Filing History

Browse ESGEN Acquisition's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
04/24/2026 4:20 PM
ESGEN Acquisition (1865506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2026 3:05 PM
ESGEN Acquisition (1865506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2026 3:15 PM
Larsen Kalen (2014406) Reporting
ESGEN Acquisition (1865506) Issuer
Form 5
Annual statement of changes in beneficial ownership of securities  
03/10/2026 3:15 PM
BRIDGEWATER TIMOTHY A (1281253) Reporting
ESGEN Acquisition (1865506) Issuer
Form 5
Annual statement of changes in beneficial ownership of securities  
02/23/2026 2:20 PM
Guy Gianluca (2014394) Reporting
ESGEN Acquisition (1865506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2026 4:08 PM
ESGEN Acquisition (1865506) Filer
Form 424B3
02/03/2026 4:08 PM
ESGEN Acquisition (1865506) Filer
Form 424B3
02/01/2026 11:15 PM
ESGEN Acquisition (1865506) Filer
Form EFFECT
12/23/2025 3:15 PM
Bridgewater Brandon (2014429) Reporting
ESGEN Acquisition (1865506) Issuer
Form 4/A
12/12/2025 5:16 PM
Bridgewater Brandon (2014429) Reporting
ESGEN Acquisition (1865506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 4:00 PM
Bridgewater Brandon (2014429) Reporting
ESGEN Acquisition (1865506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2025 3:32 PM
Hruby Anton (2014455) Reporting
ESGEN Acquisition (1865506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2025 5:15 PM
Hruby Anton (2014455) Reporting
ESGEN Acquisition (1865506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2025 2:08 PM
Bridgewater Brandon (2014429) Reporting
ESGEN Acquisition (1865506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2025 4:00 PM
LHX Intermediate, LLC (2046915) Filed by
ESGEN Acquisition (1865506) Subject
Form SCHEDULE 13D/A
11/20/2025 4:00 PM
LHX Intermediate, LLC (2046915) Reporting
WHITE OAK GLOBAL ADVISORS LLC (1420562) Reporting
ESGEN Acquisition (1865506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 4:00 PM
LHX Intermediate, LLC (2046915) Reporting
WHITE OAK GLOBAL ADVISORS LLC (1420562) Reporting
ESGEN Acquisition (1865506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2025 7:01 AM
ESGEN Acquisition (1865506) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2025 3:47 PM
Guy Gianluca (2014394) Reporting
ESGEN Acquisition (1865506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/28/2025 3:18 PM
ESGEN Acquisition (1865506) Filer
Form S-1
Registration statement under Securities Act of 1933  
09/08/2025 7:00 AM
ESGEN Acquisition (1865506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2025 3:33 PM
Bridgewater Brandon (2014429) Reporting
ESGEN Acquisition (1865506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2025 3:34 PM
Larsen Kalen (2014406) Reporting
ESGEN Acquisition (1865506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 3:03 PM
Hruby Anton (2014455) Reporting
ESGEN Acquisition (1865506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2025 4:40 PM
Bridgewater Brandon (2014429) Reporting
ESGEN Acquisition (1865506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025 4:40 PM
Larsen Kalen (2014406) Reporting
ESGEN Acquisition (1865506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2025 3:15 PM
Larsen Kalen (2014406) Reporting
ESGEN Acquisition (1865506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2025 3:15 PM
Bridgewater Brandon (2014429) Reporting
ESGEN Acquisition (1865506) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2025 12:08 PM
Larsen Kalen (2014406) Reporting
ESGEN Acquisition (1865506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2025 3:00 PM
Bridgewater Brandon (2014429) Reporting
ESGEN Acquisition (1865506) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2025 4:31 PM
ESGEN Acquisition (1865506) Filer
Form 424B7
08/12/2025 8:02 AM
Adage Capital Management, L.P. (1535978) Filed by
ESGEN Acquisition (1865506) Subject
Form SCHEDULE 13G/A
08/11/2025 6:24 AM
ESGEN Acquisition (1865506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2025 6:38 PM
ESGEN Acquisition (1865506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2025 3:15 PM
ESGEN Acquisition (1865506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2025 11:15 PM
ESGEN Acquisition (1865506) Filer
Form EFFECT
07/13/2025 11:15 PM
ESGEN Acquisition (1865506) Filer
Form EFFECT
07/11/2025 3:31 PM
ESGEN Acquisition (1865506) Filer
Form 424B3
05/29/2025 3:12 PM
ESGEN Acquisition (1865506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2025 6:59 AM
ESGEN Acquisition (1865506) Subject
Form 425
05/29/2025 6:57 AM
ESGEN Acquisition (1865506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2025 7:43 AM
ESGEN Acquisition (1865506) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025 7:38 AM
Taconic Capital Advisors LP (1390113) Filed by
ESGEN Acquisition (1865506) Subject
Form SCHEDULE 13G/A
(Data available from 1/1/2016 forward)

ESGEN Acquisition SEC Filings - Frequently Asked Questions

ESGEN Acquisition (ESACW) has submitted 157+ filings to the SEC since 2022. You can browse the complete history or filter by form type using the tools above.

The most recent filing was a Form 8-K submitted on April 24, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:ESACW) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners